AI Article Synopsis

  • A study analyzed the effectiveness of the modified ACC/AHA lesion classification as a way to predict short- and long-term outcomes in patients undergoing percutaneous coronary intervention (PCI) with second-generation drug-eluting stents.
  • Data from 8,516 patients revealed that those with complex lesions (B2/C) experienced higher instances of target lesion failure (TLF) compared to those with noncomplex lesions (A/B1) at multiple follow-up points (30 days, 1 year, and 5 years).
  • The findings suggest that the historical ACC/AHA classification system remains relevant for predicting clinical outcomes after PCI, particularly highlighting worse outcomes for complex lesions after 5 years.

Article Abstract

Background Use of the modified American College of Cardiology (ACC)/American Heart Association (AHA) lesion classification as a prognostic tool to predict short- and long-term clinical outcomes after percutaneous coronary intervention in the modern drug-eluting stent era is uncertain. Methods and Results Patient-level data from 7 prospective, randomized trials were pooled. Clinical outcomes of patients undergoing single lesion percutaneous coronary intervention with second-generation drug-eluting stent were analyzed according to modified ACC/AHA lesion class. The primary end point was target lesion failure (TLF: composite of cardiac death, target vessel myocardial infarction, or ischemia-driven target lesion revascularization). Clinical outcomes to 5 years were compared between patients treated for noncomplex (class A/B1) versus complex (class B2/C) lesions. Eight thousand five hundred sixteen patients (age 63.1±10.8 years, 70.5% male) were analyzed. Lesions were classified as A, B1, B2, and C in 7.9%, 28.5%, 33.7%, and 30.0% of cases, respectively. Target lesion failure was higher in patients undergoing percutaneous coronary intervention of complex versus noncomplex lesions at 30 days (2.0% versus 1.1%, =0.004), at 1 year (4.6% versus 3.0%, =0.0005), and at 5 years (12.4% versus 9.2%, =0.0001). By multivariable analysis, treatment of ACC/AHA class B2/C lesions was significantly associated with higher rate of 5-year target lesion failure (adjusted hazard ratio, 1.39 [95% CI, 1.17-1.64], =0.0001) driven by significantly higher rates of target vessel myocardial infarction and ischemia-driven target lesion revascularization. Conclusions In this pooled large-scale analysis, treating complex compared with noncomplex lesions according to the modified ACC/AHA classification with second-generation drug-eluting stent was associated with worse 5-year clinical outcomes. This historical classification system may be useful in the contemporary era for predicting early and late outcomes following percutaneous coronary intervention.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798816PMC
http://dx.doi.org/10.1161/JAHA.121.025275DOI Listing

Publication Analysis

Top Keywords

target lesion
20
clinical outcomes
16
percutaneous coronary
16
coronary intervention
16
lesion failure
12
lesion
9
acc/aha lesion
8
lesion classification
8
randomized trials
8
outcomes percutaneous
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!